Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma

Lung adenocarcinoma is often diagnosed at an advanced stage with poor prognosis. Patients with different clinical outcomes may have similar clinico-pathological characteristics. The results of previous studies for biomarkers for lung adenocarcinoma have generally been inconsistent and limited in cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ya-Hsuan, Chen, Chung-Ming, Chen, Hsuan-Yu, Yang, Pan-Chyr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455286/
https://www.ncbi.nlm.nih.gov/pubmed/26042604
http://dx.doi.org/10.1038/srep10979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455286/
https://www.ncbi.nlm.nih.gov/pubmed/26042604
http://dx.doi.org/10.1038/srep10979

Ejemplares similares